Purchase this article with an account.
Lennart Berglin, Sylvia Sarman, Ingeborg van der Ploeg, Björn Steen, Yue Ming, Shigeyoshi Itohara, Stefan Seregard, Anders Kvanta; Reduced Choroidal Neovascular Membrane Formation in Matrix Metalloproteinase-2–Deficient Mice. Invest. Ophthalmol. Vis. Sci. 2003;44(1):403-408. doi: 10.1167/iovs.02-0180.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
purpose. Findings in studies have suggested a role for matrix metalloproteinase (MMP)-2 in angiogenesis, including choroidal neovascularization (CNV). To investigate further, the current study was conducted to observe the formation of experimental CNV in MMP-2–deficient mice.
methods. CNV was induced in wild-type and MMP-2–deficient mice by krypton laser photocoagulation of the fundus. The time-course of expression of MMP-2 mRNA after laser treatment was determined by in situ hybridization with anti-sense and sense cRNA probes. MMP-2 protein distribution was determined by immunohistochemistry. Ten days after treatment, the extent of CNV was evaluated on hematoxylin-eosin stained serial sections. The maximum height of the CNV lesions was calculated by image analysis of digitized histologic images.
results. Expression of MMP-2 mRNA was detected in the CNV lesions at day 3 after laser treatment and peaked at day 5, after which it slowly declined. MMP-2 mRNA expression appeared to be highest at the margins of the membrane. Immunostaining for MMP-2 confirmed the presence of MMP-2 protein in the CNV lesions. The CNV lesions of MMP-2–deficient mice showed that relative thickness was reduced by 31% compared with wild-type mice (P = 0.006).
conclusions. The present study demonstrated that MMP-2 mRNA and protein are upregulated during experimental CNV in the mouse. The marked difference in thickness of the CNV membrane between wild-type and MMP-2–deficient mice shows that MMP-2 is involved in the formation of experimental CNV in the mouse. These results suggest that pharmacologic targeting of MMPs, including MMP-2, may reduce formation of CNV in conditions such as age-related macular degeneration.
This PDF is available to Subscribers Only